Page 1,370«..1020..1,3691,3701,3711,372..1,3801,390..»

50 Top Women in STEM | The Best Schools

Posted: July 15, 2018 at 1:41 am

By James A. Barham

They say that success is the best revenge.

For every woman who has ever felt exasperated by the various speculations regarding the existence or non-existence of innate differences between the sexes with respect to mathematical ability, what better rebuttal could there be than a list like this one?

The very fact that these fifty women have achieved what they have shows the superficiality of the whole debate. It ought to be clear by now that the mature expression of sophisticated human capacities depends upon a complex interaction between biological endowment and cultural and educational opportunity (that is, nature and nurture).

And if someone were to object that these fifty women are not typical well, the men who could be accounted the peers of these women would constitute a tiny minority of their sex, as well! Very high achievement, by its very nature, is something out of the ordinary.

Even readers who may have no interest at all in the nature-nurture problem and its echo in our present culture wars ought to take notice of this list. Why is that?

Consider this. Practically everyone allows that the fields of science, technology, engineering, and math (STEM) hold the key to the economic future of our country. Moreover, today well over half of all college graduates are female. In fact, women have been increasing their numbers in other academic fields by leaps and bounds in recent years; in STEM fields, not so much.

Therefore, we submit that the entrance of women into STEM fields in greater numbers is of vital importance to our national interest.

Also note that in order to compile this list, we had no recourse at all to affirmative action. There was simply no need for it. If anyone finds our list empowering, we are happy for them, but that is not really the main point.

We simply looked for the best women in their respective fields women who have gotten where they are by simply plowing through whatever obstacles may have stood in their path. Women with a lot of innate talent, certainly, but who have also put in a great deal of extremely hard work.

In other words, what our list shows to todays young women and whoever else may be interested is that it can be done. If a young woman has a taste and a talent for math and science and a capacity to stick with it to accomplish her goals that is really all she needs. At the end of the day, everything else is sound and fury signifying very little. (If youre up of a fun little challenge to test your skills, check out our STEM Intelligence Quiz.)

In short, the highly accomplished women on this list provide the best sort of role models for mathematically and scientifically inclined younger women. They say it loud and clear, for all the world to hear:

Just get out of my way, and let me get on with the work!

Note: We have tried to balance our list which is alphabetical among the various STEM fields, and within the exact sciences, among the main disciplines, such as physics, chemistry, biology, astronomy, and geology. To be selected for inclusion on this list, the woman had of course to be still living as of the date of publication, and also be born after 1937 (and thus be under the age of eighty). We reluctantly decided to institute an age requirement in order ensure a list with more younger scholars still engaged in active research. We hope to revisit the path-breaking achievements of older women scientists on another occasion.

Askins (ne Scott) was born in Belfast, Tennessee. After first working as a teacher and raising a family, she went back to school and took her bachelors and masters of science degrees from the University of Alabama in Huntsville. She was then employed as a physical chemist by NASAs Marshall Space Flight Center in Huntsville.

Askins is best known for inventing the autoradiograph, a method of greatly enhancing the density and contrast of photographic images by exposing the silver in the emulsion of a photographic negative to radiation, and then creating a second image by exposing a second emulsion to the radiation from the first one. Askinss process was initially applied with great success in astronomy, to images taken through light telescopes. Subsequently, it found wide application in medical technology, in the enhancement of X-ray images. In 1978, Askins was named Inventor of the Year by the Association for the Advancement of Inventions and Innovations the first woman to receive the honor.

Bertozzi was born in Boston, Massachusetts. She received her AB summa cum laude in chemistry from Harvard University. She received her PhD in chemistry in 1993 from University of CaliforniaBerkeley, where she worked with Mark Bednarsky on the synthesis of oligosaccharide analogs. She joined the Berkeley faculty in 1996. Today, she is Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences at Stanford University, as well as Director of the Bertozzi Research Lab in the Department of Chemistry at Stanford. In addition, since 2000 she has been a Howard Hughes Medical Institute investigator.

Bertozzis research focuses on the role of glycans (polysaccharides) in cell surface receptors, especially the connection between cell-signaling disruption and diseases like cancer and arthritis. Her lab is perhaps best known for developing powerful new research tools for cell biology, notably so-called bioorthogonal chemical reporters, which are man-made chemical handles that can be altered by means of externally controlled but non-perturbing reactions within the living system basically a new way of designing macromolecules to order. Bertozzis new method has been essential, among other things, to the development of modern forms of fluorescent labeling of macromolecules for purposes of advanced imaging. Bertozzi has won numerous prizes and awards, and is involved in several start-ups and other commercial ventures connected to her pioneering work.

Blackburn was born in Hobart, Tasmania, in Australia. When she was sixteen, her family relocated to Melbourne, where she attended high school, and obtained her bachelors and masters of science degrees from the University of Melbourne. Next, she traveled to the United Kingdom, where she enrolled in Darwin College, Cambridge, obtaining her PhD in 1974 for work on bacteriophage viruses. After graduating, she taught at University of CaliforniaSan Francisco, where her ground-breaking work on telomeres was done. She is currently President of the Salk Institute for Biological Studies in La Jolla, California.

In 2009, Blackburn was awarded the Nobel Prize for Physiology or Medicine, along with Carol W. Greider (see below on this list) and Jack W. Szostak, for her discovery of telomerase, a member of the reverse transcriptase family of enzymes. Telomeres are non-coding buffer regions at the ends of chromosomes which become shortened during chromosome replication. Telomerase controls the bonding of new nucleotide units to the shortened telomere regions after completion of cell replication, a function that is vital to the longevity of the cell. in 2002, Blackburn was appointed to the Presidents Council on Bioethics by President George W. Bush. She supported the use of human embryonic stem cells in biomedical research, which put her at odds with the majority of the Council. In 2004, she was removed from her position on the Council by President Bush amid heated public controversy.

Blau was born in London, but earned her bachelors degree from the University of York in the United Kingdom. She obtained her MA and PhD degrees from Harvard University, where she worked under Fotis C. Kafatos. After a postdoc as University of CaliforniaSan Francisco, she joined Stanford University in 1978, where she received an endowed chair in the Department of Microbiology and Immunobiology in 1999. In 2002, she was appointed as the founding Director of the Baxter Laboratory for Stem Cell Biology at Stanford.

Blau is best known for her experiments with heterokaryons (fusions of differentiated cells from two different species), work which proved that even mature, differentiated cells retain the latent capacity for the expression of different cell types, and that mature cell type could in fact be reversed something that had previously been assumed to be impossible. Her work also showed that the maintenance of the differentiated cell state is the result of a continuing, active process which points to a new, more dynamic vision of all living processes. Blaus work is considered to be fundamental to the young but burgeoning fields of stem cell biology and regenerative medicine. Her work also has profound implications for our eventual understanding of the physiological basis of cancer.

Breazeal was born in Albuquerque, New Mexico. She received her bachelor of science degree in electrical and computer engineering from University of CaliforniaSanta Barbara in 1989, and her doctor of science degree in electrical engineering and computer science from Massachusetts Institute of Technology in 2000. At MIT, Breazeal worked in the Artificial Intelligence Laboratory under Rodney A. Brooks, fabled pioneer of the actionist approach to robotics. For her doctoral dissertation, she developed Kismet (see video clip, below), a highly expressive humanoid robot capable of unscripted, emotionally intuitive, and hence lifelike interaction with human beings.

Following the breakthrough with Kismet, Breazeal helped develop a number of more sophisticated robots utilizing similar principles, including Cog, Leonardo, and Nexi. The general term now in use for these more-advanced descendants of Kismet is MDS (mobile, dexterous, social) robots. Several commercial spin-offs have been derived from her work, as well, including the personal trainer, Autom, the interactive robot companion, Huggable, and the enhanced video-conferencing system, MeBot. Breazeal is currently Director of the Personal Robots Group under the aegis of MITs famed Media Lab.

Buck was born in Seattle, Washington. She received her bachelor of science degree in psychology and microbiology from the University of Washington at Seattle in 1975, and her PhD in immunology from the University of Texas Southwestern Medical Center in Dallas in 1980. At the latter institution, she worked under Ellen S. Vitetta, co-discoverer of the cytokine Interleukin-4, which plays an essential role in the formation of T cells. After a couple of years of postdoctoral research at Columbia University, Buck joined Richard Axels lab at Columbias Institute of Cancer Research.

Inspired by the pioneering work of Solomon H. Snyder during the 1970s on the opioid receptor in the brain (as well as the receptors for many other major neurotransmitters), Buck and Axel decided to try to map an entire sensory system at the molecular level. They chose the olfactory system in rats for its relative simplicity. Beginning in 1991, they began publishing work that eventually identified genes and gene families responsible for coding for more than 1,000 different neural receptors (sensors) in the olfactory receptor cells at the back of the nose at the base of the brain. For this ground-breaking work, Buck and Axel received the 2004 Nobel Prize for Physiology or Medicine. In 1991, Buck joined the Neurobiology Department of Harvard Medical School, where she soon became head of her own lab. There, she traced the molecular basis of olfaction still further, showing how information from the various receptor cells are integrated in the olfactory bulb before being passed on to higher-level structures in the brain for interpretation. Buck is currently a Full Member of the Basic Sciences Division at Fred Hutchinson Cancer Research Center in Seattle.

Burnell (ne Bell) was born in Lurgan, Northern Ireland, in the United Kingdom. She became interested in astronomy at an early age. She took her bachelors degree in physics in 1965 from the University of Glasgow, and received her PhD in 1969 from the University of Cambridge. While at Cambridge and still known as Jocelyn Bell she was enlisted by her doctoral adviser, Antony Hewish, to work with Martin Ryle and others on the construction and testing of a new radio telescope designed to study the then-recently discovered radio sources known as quasi-stellar objects, or quasars. In 1967, while poring over data from the new telescope, Bell discovered a never-before-observed type of signal being emitted with great regularity at the rate of about one and one-third pulses per second. She immediately showed the strange signal to her adviser, and the two worked closely together to try to understand what she had found.

Initially given the facetious name of LGM-1 (for little green men) by Bell and Hewish, their discovery was soon conjectured by Thomas Gold to be caused by a highly magnetized, rapidly rotating neutron star. This conjecture proved to be correct, and the phenomenon then became officially known as a pulsating star, or pulsar. In 1968, Bell married Martin Burnell and, after taking her degree the following year, at first worked only part-time. Eventually, the couple divorced and Burnell resumed a full-time academic career, initially as Professor of Physics at the Open University (1991 2001). After occupying a visiting professorship at Princeton University, she next served as Dean of Science at the University of Bath (2001 2004). During this time, she also served as President of the Royal Astronomical Society (2002 2004), and later as President of the Institute of Physics (2008 2010). She is currently Visiting Professor of Astrophysics at the University of Oxford. Though passed over for the Nobel Prize for Physics awarded to Hewish and Ryle in 1974, Burnell was elected a Fellow of the Royal Society (FRS) in 2003 and was made a Dame Commander of the Order of the British Empire (DBE) in 2007, among many other honors too numerous to mention.

Burns was born in Torrington, Wyoming (a small town of less than 7,000 souls). She earned her bachelors degree from Florida International University in Miami, and a PhD in organic chemistry from Iowa State University. She then did post-doctoral work at the University of Montpellier, France. In 1983, she joined the French division of the American company, Dow Corning, as a researcher specializing in organosilicon chemistry (the chemistry of organometallic compounds containing carbon silicon bonds). While still working for the company as a research scientist, Burns invented several new types of heat-resistant synthetic rubber made from silicone (a polymer consisting of long silicon oxygen chains, as well as carbon atoms). She holds three patents for these inventions.

Burns soon made the transition at Dow Corning from the laboratory bench to the corporate suite. In 1997, she moved to Brussels, where she oversaw important aspects of the companys European operations. In 2000, she returned to the United States in order to assume the role of Executive Vice President of the company, and to serve on its board of directors. In 2003, she was named President and Chief Operating Officer of Dow Corning, and in 2004 she added CEO to her titles, serving in that capacity until her retirement in 2011. She was also Chairman of the company from 2006 until her retirement. Under Burnss leadership, Dow Corning began developing new uses for organosilicon compounds in cutting-edge areas like solar energy and biotechnology.

Caraiani was born in Bucharest, Romania. She earned her bachelors degree summa cum laude from Princeton University in 2007. At Princeton, she wrote her senior thesis on Galois representations under the supervision of Andrew Wiles, widely known for having completed a proof in 1995 of Fermats Last Theorem. Caraiani did her doctoral work at Harvard under the supervision of Wiless former student, Richard Taylor. Her doctoral dissertation concerned local-global compatibility in the Langlands correspondence. After graduating in 2012, she first taught briefly at the University of Chicago, before returning to Princeton University from 2013 to 2016. While at Princeton, she also served as a Veblen Research Instructor in Mathematics at the Institute for Advanced Study (IAS). Since 2016, Caraiani has been a Bonn Junior Fellow at the Hausdorff Center for Mathematics (HCM), a highly prestigious mathematics research institute located in Bonn, Germany. She has also been invited for shorter visits to the Mathematical Sciences Research Institute at University of CaliforniaBerkeley and the cole Normale Suprieure in Paris.

So far, Caraiani has worked primarily on problems at the interface of the Langlands correspondence with arithmetic algebraic geometry. (The local Langlands correspondences are a part of the overarching Langlands program, which explores conjectured deep connections among diverse areas of mathematics, such as number theory, algebra, and analysis.) Regarding the direction of her future research, Caraiani has said that she hopes to extend the results, in work done jointly with Peter Scholze, about torsion in the cohomology of compact unitary Shimura varieties to the non-compact case. In the spring of 2018, Caraiani is due to take up a position as a von Neumann Fellow at the IAS.

Charlesworth (ne Maltby) was born in the United Kingdom. She received her PhD in genetics in 1968 from Cambridge University. Married to the geneticist Brian Charlesworth in 1967, for many years she followed in the wake of his career, holding only temporary positions at a number of institutions, including Cambridge University, the University of Chicago, Liverpool University, the University of Sussex, and the University of North Carolina, before finally received a full-time appointment as Assistant Professor at the University of Chicago in 1988. In 1997, she moved to the University of Edinburgh, where she is currently a Professorial Research Fellow.

Charlesworth has made signal contributions to our understanding of population genetics and evolution, especially in relation to genetic recombination, sex chromosomes, and mating systems in both plants and animals. More particularly, her work on linkage disequilibrium in the genome region containing the self-incompatibility alleles of the plant Arabidopsis lyrata has been widely recognized as highly original and important. Charlesworth has published more than 300 research papers, which have been cited more than 10,000 times. In 2005, she was named a Fellow of the Royal Society.

Chowdhry was born in Mumbai (then Bombay), India. She received her bachelors degree from the Indian Institute of Science in Mumbai in 1968. In 1970, she received a masters degree in engineering from the California Institute of Technology (Caltech), in Pasadena, California. After working for two years with the Ford Motor Company, she returned to graduate school, taking her PhD in materials science from Massachusetts Institute of Technology in 1976. The following year, Chowdhry joined the DuPont company as a research scientist at the DuPont Experimental Facility in Wilmington, Delaware.

While still at the laboratory bench, Chowdhry worked primarily on developing new ceramic materials for the field of high-temperature superconductivity. This work generated over fifty research papers and twenty patents. In addition to her work on ceramics and superconductors, she has also worked in the areas of catalysis, proton conductors, microelectronics, and nanotechnology. In 2002, she was named DuPonts Vice President of Global, Central Research & Development. In 2006, she became Senior Vice President of the company, as well as Chief Science and Technology Officer, positions she continued to hold until her retirement in 2010. In 2003, Chowdhry was elected to the American Academy of Arts and Sciences.

Cummings was born in a small town in Tennessee. Cummings received her bachelors degree in mathematics from the United States Naval Academy in 1988. She received her masters degree in space systems engineering from the Naval Postgraduate School in 1994, and her PhD in Systems Engineering from the University of Virginia in 2004. From 1988 until 1999, Cummings was a naval officer and military pilot. In 1989, she was one of the first women to land a supersonic jet fighter a Boeing F/A-18 Hornet on the deck of an aircraft carrier.

Cummings began her academic career while still in the Navy, at Pennsylvania State University, afterwards also teaching at Virginia Tech. In 2010, MIT appointed her an Associate Professor in its Department of Aeronautics and Astronautics, where she was Director of the Humans and Automation Lab in the Engineering Systems Division. She is currently Associate Professor in the Department of Mechanical Engineering and Materials Science at Duke University, where once again she is Director of the Humans and Autonomy Lab (the new incarnation of the lab she previously headed up at MIT). She also holds joint appointments with Dukes Institute of Brain Sciences and Electrical and Computer Engineering Department. Cummingss research extends across several fields, including human interaction with autonomous vehicle systems, modeling human interaction with complex systems, and decision support design for time-pressured, uncertain systems. In addition, she has a strong interest in the ethics of technology, including the impact of technology on society.

Curry took her bachelors degree in geography from Northern Illinois University in 1974, and her PhD in geophysical sciences from the University of Chicago in 1982. In 2017, under intense pressure and amid public controversy, she resigned her long-time position as Professor in the School of Atmospheric Sciences at Georgia Tech University, where she had served as Chair of the School from 2002 until 2013. Prior to coming to Georgia Tech, Curry had been Professor of Atmospheric and Oceanic Sciences at the University of Colorado-Boulder, and before that had taught at a number of other prestigious universities, including Penn State, Purdue, and the University of Wisconsin-Madison. She has published nearly 200 peer-reviewed papers, and is co-author or -editor of three important textbooks: with Vitaly I. Khvorostyanov, Thermodynamics, Kinetics, and Microphysics of Clouds (Cambridge University Press, 2014); with James R. Holton and John Pyle, Encyclopedia of Atmospheric Sciences (Academic Press, 2003); and with Peter J. Webster, Thermodynamics of Atmospheres and Oceans (Academic Press, 1998). Curry has served on NASAs Advisory Council Earth Science Subcommittee, on the Climate Working Group of the National Ocean and Atmospheric Administration (NOAA), and on the National Academies Space Studies Board and Climate Research Group. In 2004, she was elected a Fellow of the American Geophysical Union, and in 2007, a Fellow of the American Association for the Advancement of Science.

In spite of these solid credentials and achievements and despite her entrenched position within the institutions of mainstream American academic climatology Curry came under vitriolic attack for publicly censuring what she perceives as the growing politicization of climate science, which she feels has resulted in claims that are not adequately supported scientifically, in the stifling of needed further research, and in intimidation, fear, and conformity throughout the discipline. It was this courageous public stance including an op-ed piece in the Wall Street Journal in 2014 and culminating in congressional testimony in 2015 and again in 2017 that eventually led to her resignation from her tenured position at Georgia Tech earlier this year.

Donald (ne Griffith) was born in London. She was educated at the Camden School for Girls and Girton College, University of Cambridge. She took her bachelors degree in theoretical physics from the latter institution, where she went on to take her PhD in 1977 for work on electron microscopy. After postdoctoral work at Cornell University in the US, where she switched the focus of her research from metals to polymers, she returned to Cambridge in 1981, and two years later became a member of the world-renowned Cavendish Laboratory there, forever associated with the name of Ernest Rutherford. Since 1998, she has been Professor of Experimental Physics at the University of Cambridge, where she is also Master of Churchill College.

Donald works within the Soft Matter and Biological Physics group at the Cavendish Laboratory. Over the years, she has moved from the study of nonliving polymer and colloidal systems to research on the soft-matter properties of living systems, especially protein aggregation. Of the many techniques at the disposal of the soft-matter physicist, she is particularly noted for her work using the environmental scanning electron microscope (ESEM), a device which allows for the study of untreated or wet specimens, and hence is of particular value for studying the physics of biological systems (macromolecules, organelles, and cells). Donalds work has placed her at the forefront of efforts to develop and institutionalize the burgeoning new field of biological physics. In 1999, she was elected a Fellow of the Royal Society (FRS), and in 2010, she was appointed a Dame Commander of the Order of the British Empire (DBE).

Doudna was born in Washington, DC, but spent most of her childhood in Hilo, Hawaii. She earned her bachelors degree in chemistry in 1985 from Pomona College and her PhD in biological chemistry and molecular pharmacology in 1989 from Harvard Medical School. At Harvard, she worked on ribozymes under Jack W. Szostak. She did post-doctoral work on the same topic at the University of Colorado-Boulder under Thomas R. Cech, who had just won the 1989 Nobel Prize in Chemistry for his co-discovery of the catalytic properties of RNA. After several years at Yale, Doudna moved to the University of California-Berkeley in 2002 in order to be near the synchrotron at the Lawrence Berkeley National Laboratory. She is currently Professor of Chemistry and of Molecular and Cell Biology in the Department of Chemistry and Chemical Engineering at University of CaliforniaBerkeley. She has published nearly 200 research papers and is co-author of a popular molecular biology textbook. However, Doudna is undoubtedly best-known for her recent involvement in the development of a powerful new method of gene editing that in a few short years has already revolutionized genetic engineering, and whose future contributions to medicine therapy as well as basic research are incalculable.

The method is called CRISPR/Cas9. CRISPR stands for clustered, regularly spaced, short palindromic repeats, and is basically a region of the bacterial chromosome that acts as a spacer between different coding regions, or genes. Cas9 is an enzyme produced by certain bacteria that acts like scissors, cutting a chromosome at the CRISPR region. The discovery of this pair of structures and how they operate together has made it possible for the first time for scientists to contemplate editing genes virtually at will. Teaming up with Emmanuelle Charpentier, now of Ume University in Sweden, Doudna published a seminal paper on the CRISP/Cas9 technique in 2012. Since then, however, other labs have claimed to have made similar discoveries independently, and there has been a considerable amount of legal wrangling over priority, the outcome of which has many important implications not just for the Nobel Prize and other forms of recognition but potentially for biotech ventures that may someday be worth billions of dollars.

As the daughter of physicist Sidney Drell, Persis Drell grew up on the campus of Stanford University, where today she is Provost. She earned her bachelors degree in mathematics and physics in 1977 from Wellesley College, and her PhD in atomic physics in 1983 from University of CaliforniaBerkeley. She did post-doctoral work at the Lawrence Berkeley National Laboratory, and in 1988, she took a position as Assistant Professor at Cornell, where she was appointed a full Professor 1998. In 2002, she moved to Stanford University as Professor and Associate Director of Research at the Stanford Linear Accelerator Center (SLAC). In 2007, she was named Director of SLAC, a position she held until 2012.

During her tenure as Director, Drell oversaw the so-called BaBar experiment conducted at SLAC by an international consortium of over 500 scientists, which was designed to study the relationship between matter and anti-matter by investigating the phenomenon of charge parity violation. The name of this important experiment (inspired by Babar the Elephant) comes from the symbols B and B (B-bar), standing for the B meson and its antiparticle, respectively. In 2014, Drell was named Dean of Stanfords School of Engineering, with joint appoints as James and Anna Marie Spilker Professor, Professor of Materials Science and Engineering, and Professor of Physics. In 2017, she became Provost of Stanford University.

Faber was born in Boston, Massachusetts. She took her bachelors degree from Swarthmore College in 1966, with a major in physics and minors in mathematics and astronomy. She received her PhD from Harvard University in 1972, with a dissertation on optical observational astronomy. In 1972, she became the first woman to join the staff of the Lick Observatory at University of CaliforniaSanta Cruz. In 1976, working with one of her graduate students, Robert Jackson, Faber observed a correlation now known as the Faber-Jackson relation between the brightness and spectra of galaxies and the orbital speeds and motions of the stars within them. In the early 1980s, now collaborating with Martin Reese and others, she published an influential series of articles on cold dark matter, proving that dark matter could not be composed of fast-moving neutrinos, and thus that the hot dark matter hypothesis must be wrong.

Next, Faber became closely involved with the development of the two Keck telescopes atop Mauna Kea, the tallest volcano on earth, on the Big Island of Hawaii. Then as now, the Kecks are the worlds most powerful optical instruments. Their highly innovative design includes a ten-meter primary mirror consisting of thirty-six hexagonal segments. Faber was crucial in selling the concept behind the original Keck instrument to governments and private funding agencies around the world, changing forever the face of optical astronomy. She remained closely involved with the development of the second-generation Keck II telescope, as well as with plans for the wide-field planetary camera for the Hubble Space Telescope. When a flaw was discovered in the Hubbles main optical system, Faber was charged with putting together a team, which diagnosed the cause as spherical aberration, thus permitting a technical fix to salvage the mission. The Hubble went on to a long and fruitful career producing many outstanding images of the far reaches of the universe. Faber is currently University Professor of Astronomy and Astrophysics at University of CaliforniaSanta Cruz.

Freedman was born in Toronto, where she received her bachelors degree in astronomy from the University of Toronto in 1979. She remained there for her graduate work, as well, taking her PhD in astronomy and astrophysics from the same university in 1984. Upon graduation, she joined the staff of the Carnegie Observatories, which operate the telescopes at Las Campanas, high in the Andes mountains of northern Chile, but whose headquarters are in Pasadena, California. She worked there first as a post-doc, then three years later as a regular faculty member, becoming the first woman on the permanent staff. While at the Carnegie, where in 2003 she became the Crawford H. Greenewalt Chair and Director of Observatories, Freedman worked on refining estimates of the size and age of the universe based on improved observations of Cepheid variable stars. The known relation between the periodicity of the rotation and the brightness of these stars has long been one of the main tools astronomers use to calculate intergalactic distances.

After the Hubble Space Telescope became operational in the mid-1990s, Freedman was selected to be co-leader of the Intergalactic Distance Scale project, an international team tasked with using the Hubbles greatly increased observational power to refine the value of the Hubble constant, a key value upon which depends the rate of the cosmic expansion, and thus our knowledge of the size and age of the universe. For the past fifteen years or so, Freedman has been involved with another international team planning and building the next generation of earth-based, optical telescopes, the Giant Magellan Telescope (GMT). With seven segments collectively equivalent to an 80-ft. primary mirror, the GMT is being built at the Las Campanas site in the Andes under the auspices of the Carnegie Observatories. When fully operational around 2025, the GMT will be the worlds largest optical instrument, with a resolving power an order of magnitude greater than the Hubbles. In 2014, Freedman moved to the University of Chicago, where she the John & Marion Sullivan University Professor of Astronomy and Astrophysics.

Freese was born in Freiburg, Germany (West Germany, at the time). Brought to the US at the age of nine, she received her bachelors degree in physics in 1977 from Princeton University (the second woman there to major in the subject), her masters degree in physics in 1981 from Columbia, and her PhD in physics in 1984 from the University of Chicago, where David Schramm directed her dissertation. After post-docs at the Harvard-Smithsonian Center for Astrophysics, at the Kavli Institute for Theoretical Physics at University of CaliforniaSanta Barbara, and at University of CaliforniaBerkeley, she was hired as an Assistant Professor at MIT, where she taught from 1987 until 1991. Subsequently, she moved to the University of Michigan, where she is currently George E. Uhlenbeck Professor of Physics.

Freeses main area of research has been on the dark matter/dark energy problem. In particular, she has made several proposals for ways to detect dark matter experimentally, which have led directly to the IceCube Neutrino Observatory at the AmundsenScott South Pole Station in Antarctica, and a worldwide consortium of efforts to detect a dark matter wind as the Earth and the solar system orbit the Milky Way galaxy. Her work has definitely ruled out the MACHO (massive compact halo object) theory of dark matter, thus giving support to WIMPs (weakly interacting massive particles). In more recent theoretical work, Freese has advanced several conjectures regarding dark matter, including a model known as the Cardassian expansion which replaces dark matter with a modification of Einsteins field equations, and another hypothesis known as dark stars, which if confirmed would be a new type of star powered by dark matter annihilation rather than fusion. Finally, Freese has also worked on improving the inflationary version of the Big Bang model of the origin of the universe. Her proposal, known as natural inflation, is a theoretically well-motivated idea that uses axion-like particles to provide the required flat potentials to drive the cosmic expansion. In 2013, the European Space Agencys Planck Satellite observed data which are consistent with Freeses natural inflation model.

Geller was born in Ithaca, New York. She received her bachelors degree in physics in 1970 from University of CaliforniaBerkeley, and her PhD in physics in 1975 from Princeton, where she worked with P.J.E. Peebles. After post-docs at the Harvard-Smithsonian Center for Astrophysics and the Institute for Astronomy at the University of Cambridge, she returned to Harvard, where she served as an Assistant Professor of Astronomy from 1980 until 1983. She then moved to the Smithsonian Astrophysical Observatory (a partner in the Harvard-Smithsonian Center for Astrophysics), where she has worked ever since as a member of the permanent scientific staff. Geller is a Fellow of the American Association for the Advancement of Science, of the American Physical Society, and of the American Academy of Arts and Sciences, as well as a member of the physics section of the US National Academy of Sciences. She has also received numerous prizes and lectureships, including the Newcomb Cleveland Prize (AAAS) in 1989, a MacArthur Foundation Fellowship in 1990, the Henry Norris Russell Lectureship (American Astronomical Society) in 2010, the Julius Edgar Lilienfeld Prize (American Physical Society) in 2013, and the Karl Schwarzschild Medal (German Astronomical Society) in 2014.

In order to help promote public interest in astronomy and physics, Geller lectures frequently all around the world, and has made a number of educational short films and videos. Her particular field of expertise is the large-scale structure of the universe, and her best-known scientific achievement is the creation of pioneering maps of galaxy clusters and other super-galactic structures. One such effort, the Second Center for Astrophysics Redshift Survey (CfA2) conducted in 1989 by a team of American astronomers headed up by Geller and John Huchra, led to the discovery of the Great Wall, an enormous filament of galaxies that is one of the largest known material objects in the universe.

Gianotti was born in Rome. She received her PhD in experimental particle physics in 1989 from the University of Milan. After graduation, she occupied a number of post-doc positions. In 1994, she was appointed a research physicist in the Physics Department of the Conseil Europen pour la Recherche Nuclaire (CERN) near Geneva now known officially as the European Organization for Nuclear Research (but retaining the original acronym) and site of the Large Hadron Collider, currently the worlds largest particle accelerator. Gianotti has worked at CERN ever since. She has served on the scientific advisory boards or councils of numerous international organizations, including the Centre National de la Recherche Scientifique (CNRS) in France, Fermilab in the US, the Deutsches Elektronen-Synchrotron (DESY) in Germany, and the European Physical Society.

Gianotti is a corresponding member of the Accademia Nazionale dei Lincei the most prestigious scientific society in her native Italy, which traces its roots back to the time of Galileo as well as a foreign associate member of the US National Academy of Sciences and the French Academy of Science. Moreover, in 2013, she won the Italian Physical Societys prestigious Enrico Fermi Prize. Gianotti has been involved with many important experiments at CERN over the years, but she is no doubt best known for her work as project leader of one of the two teams at CERN which undertook the search for the Higgs boson, beginning in 2009. The team she led in preparing, running, and analyzing the experiment on the Large Hadron Collider comprised some 3000 physicists from thirty-eight different countries. In July of 2012, it fell to Gianotti to make the announcement to the world that the Higgs boson had indeed been detected. In 2016, she began a five-year term as Director-General of CERN.

Greider was born in San Diego, California, and raised mostly in Davis (where her father was a physics professor). She took her bachelors degree in biology in 1983 from University of CaliforniaSanta Barbara. During this period, she spent time at the University of Gttingen in Germany, where as an undergraduate she already made important discoveries. Greider obtained her PhD in molecular biology in 1987 from University of CaliforniaBerkeley, where she worked under Elizabeth Blackburn (see above on this list). When she joined Blackburns laboratory for her doctoral work in April of 1984, Greider focused on the search for the enzyme believed to be implicated in adding new nucleotide bases to the ends of chromosomes to replace ones lost during DNA replication. Working with the fresh-water protozoan Tetrahymena thermophila as a model organism, Greider obtained the first results indicating that the enzyme now known as telomerase might be the molecule they were seeking on Christmas Day of 1984.

After six months of additional experimenting for the sake of verification, Greider and Blackburn published their ground-breaking paper on telomere terminal transferase (as they originally styled the molecule) in December of 1985. Many years later in 2009, the grad student and her adviser shared the Nobel Prize in Physiology or Medicine (along with Jack W. Szostak, who had been working along similar lines independently). After completing her dissertation, Greider worked at the world-renowned Cold Spring Harbor Laboratory on Long Island. During her time at CSHL, she worked extensively on the connection between telomeres and longevity in multicelluar aninmals, using so-called telomerase knockout mice (mice genetically altered not to produce telomerase) as her model organism. She also became involved in efforts to develop new technologies based on her discoveries, notably by joining the Scientific Advisory Board of Geron Corporation. Since 2014, Greider has been Bloomberg Distinguished Professor and Daniel Nathans Professor and Director of Molecular Biology and Genetics at Johns Hopkins University, as well as heading up the Greider Lab there.

Hau was born in the small city of Velje in Denmark. She received her bachelors, masters, and PhD degrees in physics all from the University of Aarhus. While working on her dissertation (on using silicon crystals as electrical conductors), she did research for seven months at CERN near Geneva. After graduating in 1991, she joined the Rowlands Institute for Science in Cambridge, Massachusetts, as a scientific staff member. Both at the Rowlands and after moving to Harvard in 1999 on a two-year fellowship (at the end of which she was awarded tenure), Hau began working on a pair of exotic phenomena: Bose-Einstein condensates (BEC), which occur in certain materials at ultra-low temperatures (~2 K), giving rise to unusual properties such as superfluidity; and slow light, in which the group velocity of photons interacting with a medium may be reduced far below the familiar value c the speed of light in a vacuum. Haus original application to the National Science Foundation (NSF) to fund her work on BEC was rejected on the grounds that her background was in theoretical physics and she did not have the experience to do such difficult experimental work.

Nothing daunted, she plunged ahead, gained alternative funding, and became one of the first researchers in the world to create a so-called pure BEC from a highly dilute gas (as opposed to helium-4, which is a liquid). However, she is best known for her pathbreaking work on slow light. In 1999, she and her team at Harvard used a BEC to slow a beam of light down to seventeen meters per second. Two years later, they succeeded in stopping light in its tracks. In her more recent work, Hau has been exploring novel interactions between ultracold atoms, slow light, and nanoscale systems. Her new work is thought to have great potential to revolutionize a number of different fields, from energy (photovoltaic cells, synthetic biofuels) to advanced forms of astronomical instrumentation to quantum computing. Hau is currently the Mallinckrodt Professor of Physics and of Applied Physics at Harvard University.

Jablonka (ne Tavori) was born in Poland. With her family, she emigrated to Israel in 1957. She received her bachelors degree in biology in 1976 and her masters degree in microbiology in 1980, both from Ben-Gurion University. Her masters thesis won Israels Landau Prize for outstanding masters of science work. In 1988, she earned her PhD in Genetics from the Hebrew University in Jerusalem, where she worked under the supervision of Howard Cedar. Her dissertation won her nations Marcus Prize for outstanding PhD work. While a PhD student, Jablonka served as an Assistant Professor at Ben-Gurion University, teaching courses on genetics, microbiology, and biochemistry. Both before and after obtaining her PhD, she had a series of research assistantships and teaching fellowships, notably at the Van Leer Institute in Jerusalem, the Medical Research Councils Mammalian Development Unit in London, and the Edelstein Center for the History and Philosophy of Science, Technology, and Medicine at the Hebrew University.

After teaching for several years in the Biology Department at Tel Aviv University, Jablonka moved to the Cohn Institute for the History and Philosophy of Science and Ideas there, where she is currently a Professor and lectures mainly on the history and philosophical foundations of biology. In the years since, she has had numerous visiting professorships, including at Bielefeld University in Germany and University of CaliforniaBerkeley in the US. Jablonka is mainly known for her pathbreaking work on the integration of epigenetics (AKA Lamarckian inheritance) and evolutionary theory. She is a major contributor to what has come to be called the the extended evolutionary synthesis (EES). The author or co-author of more than fifty peer-reviewed papers, Jablonka has co-authored three influential textbooks: (with Marion J. Lamb) Epigenetic Inheritance and Evolution: The Lamarckian Dimension (Oxford University Press, 1995); (also with Lamb) Evolution in Four Dimensions: Genetic, Epigenetic, Behavioral, and Symbolic Variation in the History of Life, 2nd ed. (MIT Press, 2005); and (with Eytan Avital) Animal Traditions: Behavioural Inheritance in Evolution (Cambridge University Press, 2000).

Al-Kharafi was born in Kuwait. She received her bachelors of science degree in 1967 from Ain Shams University in Cairo. She then received her masters degree in 1972 and her PhD in 1975, both from Kuwait University. While still in graduate school, she helped organize the new Corrosion and Electrochemistry Research Laboratory at Kuwait University. After graduating, she taught in the same universitys Department of Chemistry from 1975 until 1981, where she became department Chair in 1984 and a full Professor of Chemistry in 1987. From 1986 until 1989, she served as Dean of the Faculty of Science. In 1993, she was appointed Rector (an office later known as President) of Kuwait University, to help reconstruct the university in the aftermath of the trauma of the First Gulf War (19901991). The first woman to lead a major university in the Middle East, al-Kharafi remained in the post of President until 2002.

In her scientific work, al-Kharafi was primarily engaged in the study of corrosion in various technological systems, including engine cooling systems, distillation units for crude oil, and high temperature geothermal brines. She also worked on the electrochemical behavior of a wide variety of metals and metal alloys, from aluminum to vanadium to cadmium to low-carbon steel. Moreover, she collaborated in the discovery of a new class of molybdenum-based catalysts, which can be used to enhance the octane rating of gasoline without the use of undesirable benzene by-products. Al-Kharafi currently serves as a member of several boards of directors, including those of the Kuwait Foundation for the Advancement of Science and of the Kuwait-MIT Center for Natural Resources and the Environment. In addition, she is Vice-President of the World Academy of Sciences.

King was born in Evanston, Illinois, a suburb of Chicago. She received her bachelors degree in mathematics in 1966 from Carlteon College, and her PhD in genetics in 1973 from University of CaliforniaBerkeley, where she worked under Allan Wilson. Kings dissertation consisted of a comparative protein analysis of humans and chimpanzees, on the basis of which she was the first researcher to determine that the two species share the vast majority of their genes in common. (Her original figure of 99% has been revised downward only slightly over the years to around 97%.) After a post-doc at University of CaliforniaSan Francisco, King joined the University of CaliforniaBerkeley faculty as a professor of genetics and epidemiology, a position she held from 1976 until 1995, when she moved to the University of Washington. In 1990, while still at Berkeley, she discovered that a single gene on chromosome seventeen (later called BRCA-1) plays an important role in many types of breast cancer.

Not only did Kings discovery lead to genetic tests that have enabled women with a family history of breast cancer to obtain more complete information about their own prospects for coming down with the disease, the techniques she developed in the isolation of BRCA-1 have also proven extremely useful to countless other researchers working on a host of other genetic illnesses. In the intervening years, King has branched out considerably, working on the genetics of other conditions, such as deafness, but also on projects such as using genetics to help identify the remains of those killed in civil conflicts in Argentina, El Salvador, and elsewhere, as well as to reconstruct prehistoric human migration patterns. A member of the National Academy of Sciences since 2005, and recipient of the Gruber Foundation Genetics Prize (2004), the Lasker Award (2014), and honorary doctorates too numerous to mention, King is currently the American Cancer Society Research Professor at the University of Washington.

Klein was born in Wilmington, Delaware. She obtained her bachelors degree in metallurgy in 1973 and her PhD in ceramics in 1977, both from the Department of Materials Science and Engineering at MIT. Upon graduating in 1977, she joined the School of Engineering at Rutgers University, receiving tenure there in 1981 (the first woman to do so). She has been a visiting scientist at Sandia National Laboratory in Albuquerque, New Mexico, at the University of Grenoble in France, and at the Hebrew University of Jerusalem in Israel. Kleins field of scientific expertise lies in the sol-gel process, a method for producing solid materials such as glasses, ceramics, and organic-inorganic hybrid compounds from small molecules. Sol-gel processing methods refined by her have been applied to the development of a host of new devices, including ceramic membranes, solid electrolytes, fuel cell components, and planar waveguides.

Kleins best-known scientific contribution is probably her work on electrochromic window coatings. These are ceramic coatings that can be lightened or darkened through the use of a manually controlled dimmer attached to a battery. Reflecting away heat while still transmitting light in summer, as well as permitting solar heating in winter, such coatings are more versatile and efficient than traditional blinds and tintings, thus saving on heating and cooling costs. Klein is currently Distinguished Professor of Materials Science and Engineering at Rutgers University, as well as Graduate Director of the university, President of the American Association of University Professors (AAUP) there, and co-editor of the Journal of the American Ceramics Society.

Klinman was born in Philadelphia. She took her bachelors degree in 1962 and her PhD in 1966, both from the University of Pennsylvania. She did post-doctoral research at the Weizmann Institute of Science in Rehovot, Israel, where she worked with David H. Samuel, and at the Institute for Cancer Research in Philadelphia, where she worked with Irwin Rose. Klinman stayed on as a permanent scientific staff member of the Institute for Cancer Research, where she worked for many years, before moving to University of CaliforniaBerkeley in 1978. Klinmans scientific career has been devoted to the study of enzyme catalysis. In her early work, she developed kinetic isotope effects for use as an experimental probe for studying the extremely rapid individual steps involved in enzyme action. In 1990, while working with a particular copper-containing amine oxidase present in bovine blood plasma, her team discovered the presence of the topaquinone (TPQ) molecule at the enzymes active site, thus demonstrating the existence of a new class of enzymes (quinoenzymes) that require protein-derived cofactors for proper functioning.

Klinmans pathbreaking work on quinoenzymes has opened up a whole new field of study with significant theoretical and therapeutic implications. Her most recent work focuses on the role of quantum mechanical tunneling in enzyme-catalyzed hydrogen activation reactions a phenomenon she studies with new technological probes also developed by her team. In 2012, Klinman was awarded the National Medal of Science, while in 2015, she received the Mildred Cohn Award in Biological Chemistry from the American Society for Biochemistry and Molecular Biology. Klinman is currently Professor of the Graduate School and Chancellors Professor at University of CaliforniaBerkeley, where she leads the Klinman Lab in the College of Chemistry.

Liskov (ne Huberman) was born in Los Angeles, California, but grew up in the San Francisco area. She earned her bachelors degree in mathematics (with a minor in physics) in 1961 from University of CaliforniaBerkeley. She applied to the Mathematics Department at Princeton University for graduate school, but they were still not accepting female graduate students at the time. She was accepted by Berkeley, but Liskov chose instead to go to work for the Mitre Corporation, a not-for-profit, research-and-development government contractor based in the Boston area. It was at Mitre that Liskov became interested in the still-infant field of computer programming. After a year, she moved to Harvard, where she worked on the problem of automated natural language translation. After a time, she decided to go back to school, and earned her PhD in computer science from Stanford University in 1968 one of the first women anywhere to earn a doctorate in that field. At Stanford, Liskov worked closely with the artificial intelligence (AI) pioneer, John McCarthy; her dissertation was titled A Program to Play Chess Endgames. Upon graduation, she returned to Mitre, where she worked for many years as a member of their permanent research staff.

Among Liskovs many achievements in the fields of computer science and engineering are the following: the Venus operating systems (a low-cost, interactive time-sharing system); implementation of the CLU programming language and its extension, Argus (the first high-level language to support distributed programs, employing the technique of promise pipelining); and Thor (an object-oriented database system). She is also known for the eponymous Liskov Substitution Principle, an important logical/mathematical procedure in the implementation of any object-oriented programming system. In 2004, Liskov received the John von Neumann Medal bestowed by the Institute of Electrical and Electronics Engineers (IEEE), while in 2008 she won the Alan M. Turing Award bestowed by the Association for Computing Machinery (ACM) two of the highest honors in her field. Liskov is currently Institute Professor at MIT, as well as Ford Professor of Engineering in MITs Electrical Engineering and Computer Science Department in the School of Engineering.

Luu (ne Luu Le Hang) was born in Saigon, in what is now the Socialist Republic of Vietnam but was at the time the Republic of Vietnam (South Vietnam). In April of 1975, the 11-year-old Luu fled South Vietnam with her family. After some time first in a refugee camp, then with relatives living in Paducah, Kentucky, the family finally settled in Ventura, California, where Luu attended high school. She obtained a bachelors degree in physics in 1984 from Stanford University. After some time at University of CaliforniaBerkeley, she moved to MIT, where she received her PhD in the Department of Earth, Atmospheric, and Planetary Science in 1990. After several post-docs, Luu taught at Harvard and at Leiden University in the Netherlands, before returning to MIT, where she is currently a technical staff member in the Active Optical Systems Group at Lincoln Laboratory.

While a graduate student at MIT, Luu had worked closely with David C. Jewitt. When Jewitt moved to the University of Hawaii in 1988, Luu went along in order to continue working with him, while remaining an MIT student. Upon graduation in 1990, Luu took up a Postdoctoral Fellowship at the Harvard-Smithsonian Center for Astrophysics, which enabled her to continue to travel to Hawaii in order to make use of the 2.2-meter telescope atop Mauna Kea. It was there in 1992 that she and Jewitt made the discovery for which each remains best known: the Kuiper Belt, a vast disc of small, icy bodies orbiting the sun beyond Neptune. It was this discovery that eventually led to Plutos being demoted from the status of a planet to that of a Kuiper Belt object. Luu has continued to work on characterizing a great many new Kuiper Belt objects over the intervening years. In recognition of her revolutionary discoveries regarding the outer reaches of our solar system, in 2012 Luu was awarded two of the most prestigious prizes in her field: the Shaw Prize and the Kavli Prize in Astrophysics.

Mayer was born in Wausau, Wisconsin. She took her bachelors degree in symbolic systems in 1997 and her masters degree in computer science in 1999, both from Stanford University. For both degrees, she specialized in artificial intelligence (AI), including developing a travel advice software system with a natural language user interface. Upon graduation, Mayer interned at SRI International in Menlo Park, California, and at UBS Financials research lab based in Zurich, Switzerland. Next, she turned down an offer to teach at Carnegie Mellon University in order to join the then-new Google company as employee number twenty. Mayer was the companys first female engineer. She started out writing code, as well as supervising small teams tasked with the design and development of Googles search offerings. Mayer holds several patents in artificial intelligence and interface design. Moving quickly into management, Mayer placed her own personal stamp on the company, especially as the person mainly responsible for the elegant, minimalist look of Googles home page, with a single search bar centered on the page surrounded by white space. From there, she went on to oversee the launch and development of many of Googles iconic products, overseeing the development of a host of new AI-based initiatives, including Google AdWords, Google Search, Google Images, Google Maps, Google Product Search, Google Toolbar, iGoogle, and Gmail, among others.

In 2005, Mayer was named Vice President of Search Products and User Experience at Goggle. In 2011, she spearheaded Googles $125 million acquisition of the survey site, Zagat, to bolster Google Maps. During her years at Google, Mayer also frequently functioned as one of the companys most prominent spokespersons. In 2012, she was appointed President and CEO of Yahoo! However, as a result of an ultimately unsuccessful $1+ billion acquisition of Tumblr undertaken to buoy the companys sagging fortunes, as well as other controversial cost-saving and performance-enhancing measures, she became unpopular with the companys rank-and-file. Mayer resigned from Yahoo! in June of 2017, in conjunction with the companys sale to Verizon Communications. Mayer, who currently resides in San Francisco, has a net worth estimated to be around $540 million.

Miller was home-schooled in the small town of Niskayuna, near Schenectady in upstate New York. She competed on the US team at the 45th International Mathematical Olympiad in 2004 in Athens, Greece, where she won a gold medal a first ever for an American woman. She received her bachelors degree summa cum laude in mathematics in 2008 from Harvard University, where while still a undergraduate she published two papers on modular forms in number theory, and a third paper giving the best known upper bounds on superpatterns in the theory of permutation patterns. While at Harvard, she also won the Elizabeth Lowell Putnam Prize for three years running (2005 2007), equaling a record previously set by Ioana Dumitriu. Her senior thesis, Explicit Class Field Theory in Function Fields: Gross-Stark Units and Drinfeld Modules, won the Hoopes Prize. Following her bachelors degree, Miller attended Cambridge University in England for a year on a Churchill Scholarship.

Miller earned her PhD in 2014 from Princeton University, where she worked under the supervision of Fields Medalist, Manjul Bhargava. Her dissertation was titled, Counting Simple Knots via Arithmetic Invariants. Knot theory is a sub-discipline of topology with potentially important applications in quantum field theory, condensed-matter theory, and other areas of theoretical physics. After receiving her PhD, Miller returned to Harvard where she is currently a Benjamin Peirce and NSF Postdoctoral Fellow. She continues to work on algebraic number theory, arithmetic invariant theory, and their connections with classical knot invariants.

Morel was born in Issy-les-Moulineaux, a southeastern suburb of Paris. She completed her undergraduate work at the cole Normale Suprieure, and earned her PhD in 2005 at the Universit de Paris-Sud XI under the direction of Grard Laumon. Her dissertation, titled Complexes dintersection des compactifications de Baily-Borel le cas des groupes unitaires sur Q [Intersection Complexes of Baily-Borel Compactifications The Case of Unitary Groups Over Q], relates to a problem in the Langlands Program, an ambitious group of conjectures which seeks to unite various fields of mathematics such as algebraic number theory, algebraic geometry, and representation theory (a generalization of group theory) into a sort of Grand Unified Theory of mathematics.

After completing her PhD, Morel spent three years (from 2006 until 2009) at the Institute for Advanced Study (IAS) in Princeton, New Jersey, in the US. In 2009, she accepted a teaching position at Harvard University. In 2012, Morel moved to Princeton University, where she is currently a Professor of Mathematics. Since moving to Princeton, she has also been the beneficiary of two years additional affiliation with the IAS (2010 2011; 2012 2013). Moreover, between 2006 and 2011, Morel was a Clay Research Fellow under the auspices of the Clay Mathematics Institute (CMI) in Peterborough, New Hampshire. Morel continues to do research and publish on the Langlands Program.

Moser was born in Fosnavg, a small town on one of the westernmost islands off the coast of Norway. She attended the University of Oslo, where she began to study the link between brain and behavior in the laboratory of Terje Sagvolden. It was also at this time that she met her future husband and close scientific collaborator, Edvard I. Moser (the couple married in 1985). She received her undergraduate degree in general sciences with a special emphasis on neurobiology in 1983. For her masters degree, she worked in the laboratory of Per Andersen, graduating in psychology and neurobiology in 1990. For her PhD, Moser continued working in the Andersen lab, where she now focused on the the role of the hippocampus and associated neural structures in learning. During this time, she also did a stint in the lab of Richard G. Morris at the University of Edinburgh. It was Morris who had originally conceived of the water maze a specialized device for studying the process of learning in rats which Moser adapted for her own work.

Moser received her doctorate in neurophysiology in 1995, after which she occupied a short post-doctoral visiting fellowship at University College London to study with the renowned neuroscientist, John OKeefe. In 1996, she was appointed Associate Professor of Biological Psychology at the Norwegian University of Science and Technology (NTNU) in Trondheim, where she advanced to the rank of full Professor in 2000. In 2002, the group she spearheaded at NTNU became known as the Centre for the Biology of Memory. Moser also helped establish the Institute for Systems Neuroscience at NTNU in 2007. She is currently Head of Department at NTNUs Centre for Neural Computation. In 2005, Moser and her team discovered what are now known as grid cells in the entorhinal cortex, a structure within the medial temporal lobe connecting the neocortex to the hippocampus. Basically, they demonstrated that when a rat learns to navigate a maze, an isomorphic pattern of neural circuitry is established in this structure. For this pathbreaking work, Moser shared in the 2014 Nobel Prize for Physiology or Medicine (along with her husband and John OKeefe).

Nsslein-Volhard (ne Volhard) was born near Magdeburg, Germany. She studied general science at the Johann-Wolfgang-Goethe-Universitt in Frankfurt, before moving to Eberhard-Karls-Universitt in Tbingen, where she received her undergraduate degree in biochemistry in 1968. For her graduate work, she remained in Tbingen; however, she now began attending the lectures of Gerhard Schramm, Heinz Schaller, and other eminent scientists at the Max Planck Institute for Virus Research (later rechristened the Max Planck Institute for Developmental Biology). She obtained her PhD in genetics there in 1973 under the supervision of Schaller. For her dissertation, she studied the binding of RNA polymerase to the DNA molecule in Escherichia coli. Techniques she developed at this time for purifying RNA polymerase opened up new avenues for genetics research extending in many different directions.

After graduating, Nsslein-Volhard received a post-doc to work with world-renowned developmental biologist Walter Gehring at the University of Basel in Switzerland. It was in Gehrings laboratory that she undertook the painstaking work of genetic screening of mutations involving the bicaudal gene in the fruit fly (Drosophila melanogaster) on which her reputation is based. Her landmark 1977 paper, Genetic analysis of pattern-formation in the embryo of Drosophila melanogaster. turned the field of developmental biology on its ear. Scientists were now able to intervene in the development of the vertebrate embryo in a controlled way, allowing them for the first time to study the mechanistic details of embryonic development. In 1978, Nsslein-Volhard accepted a position at the European Molecular Biology Laboratory (EMBL) in Heidelberg, where she continued her groundbreaking work on Drosophila embryos, making many additional advances. In 1981, she moved to the Friedrich Miescher Laboratory, back in Tbingen, before being appointed in 1986 Director of the newly renamed Max Planck Institute for Developmental Biology, where she remains until today as an emerita researcher. In 1995, Nsslein-Volhard shared in the Nobel Prize for Physiology or Medicine (with Edward B. Lewis and Eric Wieschaus) for her work on the genetic control of early embryonic development.

Perlman was born in Portsmouth, Virginia, and grew up near Asbury Park, New Jersey. She entered MIT to study mathematics for her bachelors degree, but ended up debugging programs for the LOGO group within the Artificial Intelligence Laboratory (as it was then known) to earn some money. LOGO was an early educational robotics language. It was while working for this group under the supervision of Seymour Papert that Perlman was inspired to design a child-friendly version of LOGO called TORTIS (Toddlers Own Recursive Turtle Interpreter System), which was an interactive robot with a special keyboard that preschoolers could use to learn the basics of programming. Historians have acclaimed TORTIS as a pioneering example of tangible computing, as the field has come to be known. Perlman has stated that she failed to follow up on TORTIS for fear that the involvement of small children might prevent her from being taken seriously as a scientist. After earning her bachelors and masters degrees in mathematics from MIT, she obtained her PhD in computer science in 1988 from the same institution.

After graduating, she went to work for Digital Equipment Corporation (DEC), where she made most of the conceptual innovations for which she is famous. These include protocols she designed in the 1980s (IS-IS), which continue to be used for routing Internet Protocol (IP) to this day. She is perhaps best known for inventing the Spanning Tree Algorithm, which transformed Ethernet from its originally limited scalability into a protocol capable of handling large clouds. She later improved on this work by designing TRILL (TRansparent Interconnection of Lots of Links), which allows Ethernet to make optimal use of bandwidth. On account of these and other fundamental contributions to digital network infrastructure, she is often referred to as the Mother of the Internet a sobriquet she modestly rejects. Perlman has written two influential college textbooks her 1992 classic, Interconnections: Bridges, Routers, Switches, and Internetworking Protocols, brought simplifying clarity to a confused field and holds over one hundred patents. She is currently employed by Dell EMC.

Porco was born in the Bronx, in New York City. She earned her bachelors degree in 1974 from State University of New York (SUNY) at Stony Brook. She received her PhD in 1983 in the Division of Geological and Planetary Sciences from California Institute of Technology (CalTech), in Pasadena, California, where she wrote her dissertation on the discoveries made by NASAs unmanned spacecraft, Voyagers 1 and 2, while exploring the rings of Saturn. Immediately upon graduation, Porco joined the University of Arizonas Department of Planetary Sciences, and was appointed a member of the Voyager Imaging Team. In 1986, she was an active member of the team managing Voyager 2s encounter with Uranus, and in 1989, she headed up the Rings Working Group within the Imaging Team participating in Voyager 2s encounter with Neptune. Among the many Voyager-based discoveries attributable to Porco and her team are eccentric spokes among the rings of Saturn, the Uranian moons Cordelia and Ophelia, which shepherd Uranuss rings, and the Neptunian moon Galatea, which performs a similar function for Neptunes ring arcs.

In 1990, Porco was named leader of the Imaging Team for the Cassini space probe, which was inserted into orbit around Saturn and deployed the Huygens probe into the upper atmosphere of Saturns largest moon, Titan. During this mission, Porcos team discovered several new moons in orbit around Saturn, as well as new features of its ring system, a hydrocarbon lake on Titan, and water geysers on the moon Enceladus. In 1993, Porco coauthored a paper predicting that acoustic oscillations within Saturn are responsible for creating particular features in its ring system. This prediction was confirmed in 2013 by data collected by the Cassini spacecraft, proving that planetary rings can be used as a sort of seismograph to record oscillatory motions within a host planet. Most recently, Porco served as a member of the Imaging Team for the recent Pluto flyby mission. The author of more than 110 scientific papers, and one of the worlds experts on planetary ring formations, Porco is currently Senior Research Scientist at the Space Science Institute in Boulder, Colorado.

Randall was born in Queens, in New York City. She received her bachelors degree in physics from Harvard University in 1983, and her PhD in theoretical particle physics in 1987 from the same university, where Howard Georgi served as her dissertation adviser. After graduating, Randall held a postdoctoral fellowship at University of CaliforniaBerkeley and at the Lawrence Berkeley Laboratory until 1990, after which she returned to Harvard for a year as a member of the exclusive Junior Fellows program there. In 1991, she accepted a position as Assistant Professor of Physics at MIT, where she was promoted to Associate Professor in 1995. In 1998, Randall moved to the Princeton Department of Physics as a full Professor. After another brief stint at MIT, in 2001 she joined the Harvard Physics Department, which has been her home base ever since. She is currently the Frank B. Baird, Jr., Professor of Science in the Physics Department at Harvard, where she is also a member of the Center for the Fundamental Laws of Nature/High Energy Theory Group.

Randall works on elementary particles and fundamental forces, and has studied a wide variety of theories and models, the most recent of which involve extra dimensions of space. Moreover, she has made major contributions to such areas of theoretical physics as the standard model, the Higgs boson, supersymmetry, grand unified theories (GUTs), general relativity, cosmological inflation, baryogenesis, and dark matter. With more than 160 scientific papers to her credit, Randall is also the author of four books aimed at a popular audience, including most recently Dark Matter and the Dinosaurs: The Astounding Interconnectedness of the Universe (Ecco, 2015). In addition, she wrote the libretto for an opera, Hypermusic Prologue by Hctor Parra, based on an earlier book of hers, Warped Passages: Unraveling the Mysteries of the Universes Hidden Dimensions (Ecco, 2005). Elected a member of the National Academy of Sciences in 2008, for a time in the early 2000s Randall was one of the worlds most-cited active theoretical physicists.

Raymo was born in Los Angeles. She received her bachelors degree in geology in 1982 from Brown University. She went on to earn two masters degrees, in 1985 and 1988, from Columbia Universitys Lamont-Doherty Earth Observatory, as well as a PhD in 1989 from the same institution. After graduating, she spent a year at the University of Melbourne in Australia. Between 1991 and 2011, Raymo taught at University of CaliforniaBerkeley (briefly), at MIT, and at Boston University. For a number of years during this period, she was also an Adjunct Scientist at the Woods Hole Oceanographic Institute. In 2011, she returned to the Lamont-Doherty Earth Observatory, where she is currently Lamont Research Professor and Director of the Lamont-Doherty Core Repository.

Over the course of her career, Raymo has participated in or led field expeditions to Tibet, Patagonia, South Africa, southern India, and Western Australia, among other places. Her particular area of interest lies in understanding the causal factors responsible for the earths climate variation over geological time. This involves many different factors, including variations in the earths orbit (and thus distance from the sun), variations in solar activity, plate tectonics, and the evolution of life (and thus its contribution to the physics and the chemical composition of the land surface, the oceans, and the atmosphere). One of Raymos signal contributions to the field is her Uplift-Weathering Hypothesis (developed with William Ruddiman and Philip Froehlich). This hypothesis states that during mountain formation (tectonic uplift), such as on the Tibetan plateau, many minerals that become exposed at the surface interact with atmospheric CO2 in a process of chemical weathering, leading to a net loss of carbon to the atmosphere and a lowering of the earths mean surface temperature. The hypothesis has proved to be quite complicated in its details, and thus difficult to test. It is still being hotly debated. In 2014, Raymo received two of the most prestigious awards in her field: the Milutin Milankovic Medal of the European Geosciences Union and the Wollaston Medal of the Geological Society of London. In 2016, she was elected a member of the National Academy of Sciences.

Seager was born in Toronto, Ontario, in Canada. She earned her bachelors degree in mathematics and physics in 1994 from the University of Toronto. For he graduate work, she moved to Harvard University, where she received her PhD in astronomy in 1999. For her dissertation, Extrasolar Planets under Strong Stellar Irradiation, she worked on developing theoretical models of the atmospheres of extrasolar planets, or exoplanets, under the direction of Dimitar Sasselov. After graduating, she was a Postdoctoral Research Fellow for three years at the Institute for Advanced Study in Princeton, New Jersey. She also held a position as a Senior Research Staff member at the Carnegie Institution of Washington through 2006. In 2007, Seager joined MIT as a Associate Professor; she became a full Professor there in 2010. She is currently the Class of 1941 Professor of Physics and Planetary Science at MIT.

Seager has been at the forefront of efforts to discover and study exoplanets, particularly by analyzing their atmospheres through spectroscopic analysis. The difficulty this presents lies in the extreme faintness of the light reflected by extrasolar planets in relation to the light from the nearby stars they orbit. Seager has worked on several NASA missions past, ongoing, and in the planning stages. A future mission she is currently involved in developing will deploy a novel mechanical device to occlude starlight in order to make the closer study of exoplanets feasible. (See the video clip below for details.) Named a MacArthur Fellow in 2013, Seager is also known for the Seager Equation, a revised version of the famous Drake Equation, which provided a formula for estimating the probability of the existence of extraterrestrial life in the universe. She has co-edited (with L. Drake Deming) the volume of conference proceedings, Scientific Frontiers in Research on Extrasolar Planets (Astronomical Society of the Pacific, 2003), and authored two popular college textbooks: Exoplanets (University of Arizona Press, 2010) and Exoplanet Atmospheres: Physical Processes (Princeton UP, 2010).

Shotwell was born in Libertyville, Illinois. She received her bachelor of science degree from Northwestern University, and her masters degree in in mechanical engineering and applied mathematics from the same university. She is currently the President and Chief Operating Officer of SpaceX, a private corporation which provides spacecraft- and rocket-manufacturing and -launching services to both government and private-sector customers. SpaceX, founded in 2002 by the companys current CEO, Elon Musk, was the first private company to send a liquid-fuel rocket into earth orbit (2008) and to reach the International Space Station (2012), as well as the first group, period, to effect a propelled vertical landing of a rocket booster (2015) and to develop an integrated, vertical take-off and landing, reusable rocket system (2017).

Shotwell has been with SpaceX from the companys inception in 2002, when she was brought on board as Vice President of Business Development. Before joining SpaceX, she had worked briefly for the Chrysler Corporation, and, from 1988 until 1998, for the Aerospace Corporation, a federally funded, non-profit, research and development center. During this time, she wrote dozens of technical papers developing new concepts and analyzing operational risks in many different fields of space flight, from small spacecraft design to space shuttle integration, and from infrared signature target modeling to thermal analysis in relation to reentry vehicles. Between 1998 and 2002, she served as Director of the space systems division of Microcosm, Inc. During her early years at SpaceX, Shotwell oversaw the development of the highly successful Falcon family of launch vehicles, culminating in a commercial resupply services contract with the International Space Station. The first resupply mission was launched atop a fully reusable Falcon-9 rocket in 2012. She is currently overseeing ambitious plans to send a manned spacecraft into earth orbit next year (2018), with the eventual goal of a manned mission to Mars by 2024.

Silverstein earned her bachelors degree in physics in 1992 from Harvard University, and her PhD in physics in 1996 from Princeton University, where she studied with Ed Witten. After a post-doc at Rutgers University, in 1997 she was appointed an Assistant Professor at the Stanford Linear Accelerator Center (SLAC) now known as the SLAC National Accelerator Laboratory which is a federally owned particle accelerator laboratory operated by Stanford University. During this early stage of her career, Silverstein was also appointed a MacArthur Fellow and a Member of the Institute for Advanced Study, both in 1999. In 2001, she was promoted to Associate Professor status at SLAC, where she became a full Professor in 2006. During a sabbatical year (2009 2010), she was a Visiting Professor at the Kavli Institute for Theoretical Physics and in the Department of Physics in University of CaliforniaSanta Barbara.

Silversteins work focuses on the nature of the fundamental laws of physics, as well as the origin and early evolution of the universe. She has made important theoretical contributions to a number of different areas of current research, including the cosmic microwave background radiation, cosmic inflation, dark energy, supersymmetry breaking, the dynamics of interacting scalar fields, the unification of string vacua, and the origin of the hierarchical structure of the universe from the Planck scale to the cosmological horizon. Silverstein is perhaps best known for her work (with Allan Adams and Joseph Polchinski) on closed string tachyon condensation, resulting in the resolution of certain spacetime singularities. She is currently Professor of Physics at SLAC. Sycara has also been very active professionally, serving

Solomon was born in Chicago, Illinois. She received her bachelors degree in chemistry in 1977 from the Illinois Institute of Technology and her PhD in chemistry in 1981 from University of CaliforniaBerkeley. Upon graduating, Solomon went to work for the National Oceanic and Atmospheric Administration (NOAA) in Boulder, Colorado, where she spent the bulk of her career. There, she worked in the Aeronomy Laboratory, the Earth System Research Laboratory, and at the time of her retirement in 2011, was head of the Chemistry and Climate Processes Group. That year, she joined MITs Department of Earth, Atmospheric and Planetary Sciences. It was while working for NOAA during the 1980s that Solomon did the work upon which her reputation primarily rests. In the 1970s, it had been observed that the ozone layer on the stratosphere which screens deadly cosmic radiation and upon which all life on earth depends was becoming depleted. The problem was especially acute over Antarctica, giving rise to the phrase ozone hole.

Continued here:
50 Top Women in STEM | The Best Schools

Posted in Wyoming Stem Cells | Comments Off on 50 Top Women in STEM | The Best Schools

Stem Cell Therapy – Nebraska Orthopaedic and Sports Medicine

Posted: July 14, 2018 at 1:45 am

We are pleased to offer our newestnatural and minimally invasivetreatment alternative for joint and tendon pain.

In this procedure, bone marrow blood is removed from the pelvis, is minimally processed, and injected into the patients problem area(s) to improve joint or tendon pain.

The patients own (autologous) stem cells and platelet-rich plasma will work to stimulate the healing process of tissue that is already present.

Please note that Stem Cell Therapy is not FDA approved and is not covered by insurance.

Nebraska Orthopaedic & Sports Medicine has decades of experience providing the latest in orthopaedic procedures. We offer the entire range of treatments from conservative to surgical. The doctors at Nebraska Orthopaedic and Sports Medicine can help you choose the best treatment for YOU. Many clinics offering stem cell treatments for orthopaedic conditions are NOT orthopaedic doctors. When considering a clinic for stem cell treatment, you need to consider a doctors training and experience. Nebraska Orthopaedic & Sports Medicine is the only orthopaedic clinic in the region offering this exciting procedure.

Patients between the ages of 18-64 who have seen a physician for their condition and have exhausted all non-surgical measures (physical therapy, NSAIDs, cortisone injections, bracing, etc.) are ideal for Stem Cell Therapy

The most common areas of treatment include the hip, knee and shoulder, but can be injected into any joint or tendon causing the patient pain. All of this is done within the clinic-setting for patient comfort and convenience.

Because this is a newer treatment, the long-term outcomes are not fully understood and no guarantees can be made regarding outcomes.

Patients can expect to feel results over 1-3 months, although in some circumstances, relief may take as long as 6-9 months.

Patients interested in Stem Cell Therapy should call (402) 488-3322 to request a consultation with Scott A. Swanson, M.D.

Read more:
Stem Cell Therapy - Nebraska Orthopaedic and Sports Medicine

Posted in Nebraska Stem Cells | Comments Off on Stem Cell Therapy – Nebraska Orthopaedic and Sports Medicine

Elevating the Human Condition – Humanity+ What does it mean …

Posted: July 14, 2018 at 1:44 am

What does it mean to be human in a technologically enhanced world? Humanity+ is a 501(c)3 international nonprofit membership organization that advocates the ethical use of technology, such as artificial intelligence, to expand human capacities. In other words, we want people to be better than well. This is the goal of transhumanism.

Humannity+ Advocates for Safe and Ethical Use: Technologies that intervene with human physiology for curing disease and repairing injury have accelerated to a point in which they also can increase human performance outside the realms of what is considered to be normal for humans. These technologies are referred to as emerging and speculative and include artificial intelligence, nanotechnology, nanomedicine, biotechnology, genetic engineering, stem cell cloning, and transgenesis, for example. Other technologies that could extend and expand human capabilities outside physiology include artificial intelligence, artificial general intelligence, robotics, and brain-computer integration, which form the domain of bionics, uploading, and could be used for developing whole body prosthetics. Because these technologies, and their respective sciences and strategic models, such as blockchain, would take the human beyond the normal state of existence, society, including bioethicists and others who advocate the safe use of technology, have shown concern and uncertainties about the downside of these technologies and possible problematic and dangerous outcomes for our species.

CURRENT PROJECTS: Humanity+ @ Beijing Conference; Blockchain Prize; Humanity+ @ The Assemblage New York City; TransVision 2018 Madrid, Spain.

Read the rest here:
Elevating the Human Condition - Humanity+ What does it mean ...

Posted in Transhumanism | Comments Off on Elevating the Human Condition – Humanity+ What does it mean …

OrganiCell Regenerative Medicine Management

Posted: July 14, 2018 at 1:44 am

Regenerative Medicine

Regenerative medicine, where the body regenerates or rebuilds itself, is a relatively new and rapidly evolving front in the field of interventional pain management. Although stem cell therapy has garnered much of the attention over the past several decades, multiple other regenerative medicine modalities also have caught the publics attention. Our parent company Biotech Products Services & Research (BPSR) is a leader in developing new regenerative products and protocols.

Organicell provides the GOLD STANDARD of regenerative products for your medical practice. Our high quality, next generation, placental derived products may give a longer lasting and more profound improve quality of life for those suffering from diseases and disorders that involve pain and inflammation.

Organicell Flow is safe and easy to use. All products are tested using the highest standards for various pathogens. Organicell Flow has been independently tested to demonstrate viability. Our product contains: Pluripotent MSC, Growth Factors, Cytokines, Collagen, Hyaluronic Acid, and more.

ORGANICELL

Cells Helping Cells Makes Cellular Sense

The Human Body in Numbers

Continue reading here:
OrganiCell Regenerative Medicine Management

Posted in Regenerative Medicine | Comments Off on OrganiCell Regenerative Medicine Management

Is Stem Cell Therapy for Arthritis Safe and Effective?

Posted: July 14, 2018 at 1:43 am

People considering stem cell treatment for arthritis want to know Is it safe? and Is it effective?

Most stem cell therapy using adult stem cells is considered safe because the stem cells are collected from the patient, minimizing the risk of an unwanted reaction. The most common side effects are temporary swelling and pain.3

While most stem cell therapy for arthritis is considered safe, it does carry the same risks as any other medical procedure, such as a small risk of infection. Risk may be increased if:

See What Are Stem Cells?

Some research suggests stem cell therapy engaging in these kinds of practices may elevate the risk of tumors.4

As with most regenerative medicine treatments, research is ongoing, and FDA regulations are relatively new and subject to change.

Article continues below

Whether or not stem cells therapy is effective in treating osteoarthritis is a controversial subject among medical professionals, and research in the area is ongoing.

See Osteoarthritis Treatment

How researchers think stem cell therapy worksResearchers theorize5 that when applied to an arthritic joint, stem cells might:

See Osteoarthritis Symptoms and Signs

It may be none, one, two, or all three processes at are work.

Proponents vs criticsLike many relatively new treatments, stem cell therapy has proponents and critics.

Critics emphasize that there have been no large-scale, prospective, double-blind research studiesthe kind of clinical studies that medical professionals consider the gold standardto support stem cell therapy for arthritis.

Factors that affect stem cell therapy researchAnother challenge associated with current stem cell research is that there is no standard stem cell therapy for arthritis treatment. So the stem cell therapy in one study is not necessarily the same as the stem cell therapy in another study.

Differences can include:

These differences are further complicated by more unknowns. For example, how many stem cells are needed for a particular treatment? And how do we determine if a patients own stem cells are competent enough to aid in healing?

Many physicians combine the use of stem cells with platelet rich plasma, or PRP.

See Platelet-Rich Plasma (PRP) Therapy for Arthritis

PRP is derived from a sample of the patients blood. In the body, platelets secrete substances called growth factors and other proteins that regulate cell division, stimulate tissue regeneration, and promote healing. Like stem cell therapy, PRP therapy is sometimes used alone with the hopes of healing an arthritic joint.

See PRP Injection Preparation and Composition

Physicians who use PRP and stem cells together think that the PRP can help maximize the healing effects of stem cells.7,8 Research in this area is ongoing.

See Platelet-Rich Plasma Injection Procedure

Stem cell therapy can vary depending on the doctor performing it. People considering stem cell therapy for an arthritic knee or other joint are advised to ask their doctors questions, including:

Both doctors and patients can benefit from having a frank conversation and setting reasonable expectations.

See Arthritis Treatment Specialists

Complete Listing of References

Visit link:
Is Stem Cell Therapy for Arthritis Safe and Effective?

Posted in Stem Cell Therapy | Comments Off on Is Stem Cell Therapy for Arthritis Safe and Effective?

Cell Biology and Anatomy – University of South Carolina

Posted: July 14, 2018 at 1:42 am

Our faculty members work on research teams within the School of Medicine, the University of South Carolina system and beyond. These relationships give us access tobest-in-class technology and diverse areas of research.The partnerships have proved effective; our students and faculty have won numerous awards to support their research.

Cardiovascular Development and Congenital Birth Defects

Despite advances in our understanding of cardiovascular development, congenital defects in this system remain the leading forms of birth defects in humans. Studies are aimed at elucidating the underlying cellular and molecular mechanisms of cardiovascular development to enable better methods of detecting and treating congenital defects in this system. A variety of cutting-edge cell culture and animal models are being used in conjunction with microscopic, biochemical and molecular analyses.

Faculty:

Heart Disease and Heart Failure

Cardiovascular disease is the leading cause of death in the United States and includes a number of conditions such as atherosclerosis, myocardial infarction (heart attack), hypertension, hypertrophic cardiomyopathy and others. Studies in the department are aimed at advancing our understanding of the cellular and molecular mechanisms of heart disease and how these translate to alterations in organ function. This research requires an integrated approach across multiple disciplines and departmental faculty have formed numerous collaborations with researchers within the University of South Carolina and at other institutions. The ultimate goal of this area of research is to develop better strategies for treatment of heart disease.

Faculty:

Vascular Biology and Heart Disease

Normal function of blood vessels is critical to delivery of oxygen, nutrients and other materials to tissues of the body. Diseases of the vasculature, including atherosclerosis and aneurysms, are common, particularly in South Carolina. Research in the department is focused on elucidating the mechanisms of vascular diseases and development of more effective detection and treatment strategies for these diseases. This research includes innovative in vitro and animal models as well as examination of patient specimens. This research is performed in collaboration with investigators in the College of Engineering and Computer Science and well as clinical faculty in the Department of Surgery.

Faculty:

Reproductive Biology

Reproductive biology research in the department is focused on developmental processes of the male and female reproductive systems during postnatal development and control mechanisms in adulthood. These studies aim to understand mechanisms of infertility, endocrine disruption by environmental contaminants and the basic science of hypothalamic, anterior pituitary gland and gonadal function.

Faculty:

Biomedical Engineering

Biomedical Engineering is a rapidly growing, interdisciplinary field which involves application of engineering concepts and analytical approaches to a wide range of health-related problems, from predicting blood flow patterns in tumors to design of orthopedic devices, such as knee and hip joint replacements. The field draws on tools and conceptual frameworks, such as fluid mechanics and signal processing, from a wide spectrum of traditional engineering disciplines, including chemical engineering, mechanical engineering, electrical engineering and computer science. A number of faculty at the School of Medicine apply biomedical engineering approaches to a broad variety of medical problems and issues, which include developing new ways to repair abdominal hernias, understanding how fluid flow affects heart valve development and creating mathematical models to predict atherosclerotic plaque rupture.USC Biomedical Engineering

Regenerative Medicine

Regenerative Medicine is a rapidly evolving field that encompasses a variety of disciplines aimed at replacing, repairing or regenerating human tissues or organs to restore or establish normal function. Millions of people suffer from a vast assortment of diseases and complications that are now treated with new regenerative medicine therapies. The goal of research from a group of faculty at the School of Medicine is to develop biocompatible tissues and treatments for numerous diseases and pathologies. Heart valves, cartilage, bone, cornea and wound healing are examples of the tissues and diseases these labs study. Furthermore, many have incorporated the use of stem cells, which provide the necessary cellular component to create these in vitro constructs. As a result, the development of biocompatible tissues using the hosts owns cells have the potential to alleviate the problem of the shortage of organs available for donation.

Human Anatomy and Physiology for Biomedical Engineers (BMEN 345)

This is a systems-based course providing undergraduates in the biomedical engineering program a foundation in human anatomy and physiology. The course provides an introduction to the inter-relationships between tissue/organ structure and physiology and discussion of changes in tissue/organ structure that occur with common pathological conditions. The course also demonstrates how engineering approaches can promote understanding of these relationships. Recent biomedical engineering advances and their relation to underlying anatomy and physiology are discussed. The course includes lecture and laboratory instruction.

Advanced Female Reproductive Biology (MCBA 763)

This course is primarily a literature based course designed for graduate students with research interests in women's reproductive biology. Topics covered include the menstrual cycle of women and estrous cycles of various animals, hypothalamic-pituitary-gonadal axis, ovarian steroidogenesis, pregnancy and gonadal development. Specific disease topics covered are tailored to the student's interest may include infertility, Polycystic Ovarian Syndrome, endometriosis and fibroids.

Cardiovascular System: Development to Disease (BMEN 589)

This course is designed for graduate students who have an interest in the cardiovascular system. The course largely relies on primary scientific literature. Topics covered in the course include basic cardiovascular development and physiology as well as congenital cardiovascular defects and specific pathologies of the cardiovascular system including myocardial infarction, hypertension, atherosclerosis, valve disorders and others. Discussions are also included that center around detection and treatment of cardiovascular diseases.

Medical Embryology and Gross Anatomy (D601)

The primary goal of Medical Embryology and Gross Anatomy (MEGA) is to provide students with a basic understanding of the gross anatomy, embryology and radiologic imaging of the entire human body. This course prepares students to apply anatomy and embryology concepts to the clinical sciences and to apply radiologic imaging toward the diagnosis of clinical disorders. MEGA is an intense, integrated, 16-week regionally-based curriculum with dissections, peer teaching and learning, as well as self-directed active learning forming the basis for the laboratory. Additional lectures in embryology and imaging provide a clinical foundation for the remainder of the student's medical education.

Medical Microscopic Anatomy (MCBA D602)

The structure of cells, tissues and organs is studied and the functional significance of their morphological features is presented. Laboratory materials offer firsthand observations of structures in humans, non-human primates and other mammalian tissues through the study of digitized static labeled images and digitized images that are virtual slides when viewed using your laptop computer as a "virtual microscope." Students are expected to learn to "read" images in order to identify specific structures, cells, tissues and organs and to integrate basic concepts and principles of microscopic anatomy and histophysiology as they pertain to clinical medicine. Learning experiences are intended to foster critical thinking skills about contemporary topics that correlate basic science studies with clinical problems. The course provides the structural basis to understand principles to be learned in biochemistry, physiology, pathology and internal medicine.

Human Anatomy and Physiology for Biomedical Engineers (BMEN 723)

This is a core course for the Biomedical Engineering graduate programs, focused on human anatomy and physiology from an engineering perspective. The human body is taught from a systems-based approach with anatomy and physiology being integrated with engineering principles.

Anatomy for Health Sciences (BMSC 740)

This is an intensive cadaver-based human anatomy course taken by graduate students in health and biomedical-related areas including the Physician Assistant program at the School of Medicine. The primary goal of this course is to provide students with a broad appreciation of anatomy and the inter-relation of human structure with physiology and pathology. In addition to lecture and laboratory instruction, the course includes radiological and ultrasound imaging of anatomical structures.

Go here to read the rest:
Cell Biology and Anatomy - University of South Carolina

Posted in South Carolina Stem Cells | Comments Off on Cell Biology and Anatomy – University of South Carolina

Washington, DC – Stem Cells Transplant Institute

Posted: July 13, 2018 at 12:44 pm

There are few areas of health research that are as exciting and that hold as much potential for human health and treating disease as stem cells. Washington has been at the very forefront of stem cell therapies development.

The University of Washington Institute for Stem Cell and Regenerative Medicine is committed to the ethical pursuit of basic research to unleash the enormous potential of stem cells and thereby develop therapies and cures. Results are amazing and many people from Washington and the United States are already enjoying the benefits of stem cells therapy. United States is still in clinical trial phase and only a few clinics all over the country are legally approved.

Residents from Sammamish, Snoqualmie, Cottage Lake, Mercer Island, Bothell East and Union Hill Novelty Hill, can access today legally approved therapies in Costa Rica.

Stem Cells Transplant Institute in Costa Rica is one of the worlds leading adult stem cell therapy and research centers. We want to bring our patients from Washington stem cell-based treatments as quickly as possible with the highest standards of quality.Apply here.

The Stem Cells Transplant Institute of Costa Rica specializes in the legal treatment of Multiple Sclerosis, Diabetes, Lupus, Osteoarthritis, Rheumatoid Arthritis, Critical limb isquemia, Erectile Dysfunction, Parkinson, Neuropathy, Cardiovascular Disease, Knee Injury, Chronic Obstructive pulmonary disease, Alzheimer and Myocardial infarction.Contact us.

We use autologous Stem Cells therapies, this mean that the cells are obtained from your own fat or bone marrow, which is a very safe procedure, that plus the fact that we have one of the highest healthcare systems in the world, makes to Costa Rica the destiny of your choice. Dont hesitate tocontact us

Read more here:
Washington, DC - Stem Cells Transplant Institute

Posted in Washington Stem Cells | Comments Off on Washington, DC – Stem Cells Transplant Institute

Degrees in Biotechnology | How to Have a Biotechnology Career

Posted: July 12, 2018 at 12:49 am

Biotechnology Careers At-a-Glance

The United States leads the pack in biotech revenue, market capitalization, and the number of public biotech companies, according to a 2015 report by Ernst & Young Global Limited. In 2007, three biotechnology companies made more than one billion dollars; by the end of 2014, that number had grown to 26, and there is no end in sight to the massive growth. Biotechnology careers can be found mainly in pharmaceutical companies including Gilead Sciences, Celgene, Biogen, and Regeneron, all companies named by Forbes among the top 10 biotech companies in the country.

People who choose biotech careers have several areas of specialization to choose from. A few options include working as an epidemiologist, microbiologist, biochemist, botany specialist, agricultural and food scientist or biomedical engineer. Graduates might wind up working in a laboratory, creating new seed lines, or in a vast field, testing new soil compositions. They might work to clone animals, develop new pharmaceutical drugs, create a bionic pancreas and so much more. No matter what the career path, it all begins with rigorous study and earning a biotechnology degree.

As with all statistics, salary numbers can be deceiving. There are two reasons why the numbers below should be taken into context.

First, biotechnology careers typically require a bachelors degree for entry, but the field is filled with people who also hold masters and doctoral degrees. For instance, 45 percent of the biomedical engineers who responded to an O*NET survey said a bachelors degree was sufficient; thirty-five percent needed a masters degree and a further 20 percent needed a doctorate. Those with advanced degrees typically have higher earning potential, which partially explains how some biomedical engineers can earn around $50,000 per year while others are clearing $140,000.

Second, there are multiple employers of the scientists listed below. Some of the most prominent are universities, which typically pay less than companies engaged in applied research. Companies make profits, which can be shared with employees; universities do not.

Working in the biotechnology field starts with the proper education. Though there are numerous pathways to the various professions, some steps to success are universal. Heres how to get there.

1

Begin with the right classes

Those interested in biotechnology careers can begin their journey by taking several biology or chemistry electives while in high school. Students should also look into pursuing courses that provide both high school and college credit, such as advanced placement.

2

Start with the bachelors degree

Once high school is over, its time to move into college and earn a bachelors degree in biology, biotechnology (if offered) or a closely related field. Though there are associate degrees in biology that will form a firm foundation for the bachelors, most entry-level positions in biotechnology will require at least a bachelors degree.

3

Get experience

Learning about the job and getting hands-on training in the field can look great on a resume, as well as provide students an opportunity to decide what area of biotechnology interests them the most. Some students choose internships during their college years, while others seek out part-time or full-time work with biotech companies or labs.

4

Pursue graduate studies

In many cases, biotechnology careers will require a graduate degree for advancement. Depending upon the chosen career path, students might need to embark on their masters degree or end up with a PhD in order to do the work they really want to do.

5

Stay up-to-date

Technology is always changing, growing and shifting. Some fields of biotechnology are moving so fast that they can literally change by the week. Thats why it is so important to stay up-to-date by subscribing to industry publications, becoming active in industry associations, keeping in touch with network contacts, and otherwise staying on top of what is happening in the field.

6

Seek out new opportunities in the field

Biotechnology careers offers quite a bit of overlap; for instance, a soil and plant scientist might choose to eventually work as an agricultural and food scientist, and their education might support both paths. Seeking out new opportunities to expand on a current profession is one of the perks of working in the field, and can lead to exciting possibilities.

Those who are interested in biotechnology will discover a dizzying array of possibilities for degrees; anything from the certificate to the PhD can be helpful during the career pursuit. In addition, many biotech degrees easily adapt to online study for students who dont have the ability to attend traditional classes. Heres an overview of which degrees might be more advantageous for certain situations.

I am excited to begin work in biotechnology. I need something that will allow me to get my foot in the door while giving me a strong foundation for graduate work.

I have been working in the field for years, but there are some points that I need to brush up on times have definitely changed these last few years, and Im ready to change with it. But leaving my job to go back to school is simply not an option, as finances would be too tight.

I already have my bachelors degree, but none of my classes focused on the high-level biology I need to know in order to move into the biotech field. I need to get a bit more education while I gain experience.

I definitely want to go into biotech but I have no idea where to begin. I want to test the waters a bit and leave my options open for changing my degree path when I find what I really want to do

I grew up on a farm and love working with animals. I want to be an animal scientist, so I can help make their lives better. Its a journey that will take some serious time and effort, but Im ready for the challenge.

Ive been working in the field for a while, but promotions and pay raises seem rather elusive one manager pointed out that my educational level is holding me back. Its time to remedy that problem.

Choosing the best biotechnology degrees can be tough, as there are so many options out there. However, the desired career path often provides clues to which degree might be best, as well as which level of educational attainment is expected. Heres what students can expect to learn from each.

There are two types of biotechnology certificate programs: Those that are designed for students who have completed their graduate studies and now need more specialized training, or those who have earned their bachelors degree but didnt get all the recommended courses to move into a biotech career. The latter scenario often applies to those who have earned their bachelors in another field but have now chosen a career change to the biotechnology field.

Most certificate programs take a year or less to complete, and are very focused on the particular educational path, with little to no general education courses. Some of the common courses in a certificate program include:

This course helps students understand structural organic chemistry, chemical thermodynamics, acid base chemistry, and reaction mechanisms.

Understanding of Lewis structures

Strategic use of reaction mechanisms

Knowledge of biological molecules and how they form and interact

Students will explore the ethical issues in biotechnology, including real-world case studies and current events in the field.

Applying philosophical theories to critical current issues

Conducting human experimentation in a compassionate and ethical manner

Ethical practices regarding animal testing

This class focuses on the regulatory approval process for drugs, foods, cosmetics and more.

Proper compliance with regulatory rules

Legal implications in regulatory issues

Ethical considerations when bring a new product to market

The associate degree in biotechnology prepares students to eventually move into the bachelors degree program. Though there are some employers who will accept students who have only the associate degree, many entry-level jobs do require the four-year education. The associate degree requires four years of study to complete, though some accelerated programs might allow completion in as little as 18 months. Some common courses found in the associate in biotech program include:

This course serves as an important overview for those who are interested in the biotech field, including a look at career options.

Use of safe laboratory procedures

Understanding the variety of potential careers and how they relate to each other

Applying the basics of biotech to day-to-day life

Students will learn quality assurance principles and how they relate to the biotech fields.

Understanding the differences in regulated and non-regulated work environments

Quality system usage, including Lean and Six Sigma

Theoretical views of quality assurance as applied to real-world events

Focuses on computational biology and bioinformatics as it relates to processes and end results.

Methods for high-volume data collection

Storing and accessing biological data

Use of common programs and algorithms to analyze data

For most careers in biotechnology including that of biomedical engineer, food scientist, microbiologist, plant and soil scientist, and agricultural engineer, among others a bachelors degree is required for entry-level work. The bachelors degree typically takes four years to complete and offers some opportunities for specialization through the use of electives under the biotechnology umbrella. Some classes that students can expect to take include:

Students explore the current research in biological science and analyze it according to biotechnology principles.

Critical analysis of current research

Use of scientific reasoning to make evaluative decisions

Understanding core biological concepts

Focus on the structure and function of cells, with an emphasis on eukaryotic cell biology.

Use molecular biology knowledge to draw research conclusions

Understand DNA replication and repair

The applications of genetic engineering

An in-depth look at safety procedures and proper management of laboratory spaces.

Management of personnel, space, inventory and equipment

Proper communications with stakeholders

Compliance with all safety and health regulations

The masters in biotechnology degree allows students to enhance their knowledge through a specialized curriculum. The masters in biotech is made up of a few core courses, which are then enhanced by electives that focus on the particular educational path a student wants to carve out for themselves. The masters degree takes two to three years to complete, depending upon the program. Many programs are available online, as schools recognize the need for a flexible schedule for those who are already working in the field.

Some courses that can be found at the masters level include:

Focuses on all the aspects of project management, such as working in teams, managing time, structuring projects and more.

Consideration of each phase of a project

Communicating with a wide variety of people involved in a project

Monitoring and controlling change

Students will learn the ins and outs of federal funding and regulations, writing grant proposals, and other sources of funding for research and development.

Students will study how to apply a comprehensive validation philosophy to new ventures in biotech.

Creating equipment or processes that are less prone to failure

Designing robust yet cost-effective projects

Creating validation documents in line with rules and regulations

The doctorate is the pinnacle of the biotechnology field, and offers students quite broad autonomy when choosing an original research project and focus of study. Those who intend to work with in-depth research or move into teaching will need to earn the PhD. Some professions require it, such as that of animal scientist or biophysicist. The doctoral program usually takes between three and four years to complete, though some schools allow up to eight years for completion of the dissertation. Some courses that might be found at the PhD level include:

Students will explore cutting-edge research areas and instruments, with a rotation that takes them through biomedical and biotechnology areas.

Familiarity with the latest technologies

Refresher on how to use instruments that considered out-of-date but might be advantageous for some projects

How to balance research between different laboratories and get the same results using different systems

Students will examine upper-level biotechnology or bio-engineering problems through the lens of equations and statistics.

High-level mathematics literacy

Advanced numerical methods

Refresher on statistical analysis

Students will engage in discussions with leaders in the field on current events and ethical issues that arise from the use of technology in the biological field.

Proper development of biological products

Conducting ethical biomedical research

Marketing and transparency in presenting new biotechnologies to the public

The U.S. biotech industry grew by just about every measure in 2014, according to Ernst and Youngs 2015 industry report. Revenue was up 29 percent, net income increased 293 percent and there were 164 more biotech companies than during the previous year. All of this meant one thing for jobs: There were a lot more of them. The industry added over 10,000 new jobs in 2014, which equates to a staggering 10 percent annual growth rate. Of course, not all of these jobs were for scientists and researchers many were for support staff one might find in any industry. Jobs specific to biotechnology involving research and development and manufacturing are outlined below.

The Bureau of Labor Statistics (BLS) combines three related careers under the heading of agricultural and food scientist: animal scientist, food scientist and technologist, and soil and plant scientist. Although all have the ultimate task of improving farm productivity, they accomplish this in different ways. Each are discussed separately here.

Many people dont think of farming as being sophisticated. Seeds are planted, crops are watered, and eventually food is harvested. But it is an extraordinarily advanced field, and the largest farms are essentially food factories. Engineers are involved in research and development as well as manufacturing. They might oversee water supply and usage, design comfortable areas for the animals, and create machines that can efficiently harvest crops with minimal food loss. Agricultural engineers spend their time both in offices designing systems and on farms testing and applying those systems.

See the original post:
Degrees in Biotechnology | How to Have a Biotechnology Career

Posted in Biotechnology | Comments Off on Degrees in Biotechnology | How to Have a Biotechnology Career

Biotechnology and the Biotech Industry

Posted: July 12, 2018 at 12:49 am

Merriam-Webster defines biotechnology as the manipulation (as through genetic engineering) of living organisms or their components to produce useful usually commercial products (as pest resistant crops, new bacterial strains, or novel pharmaceuticals). Although this definition could broadly cover thousands of years of agriculture and animal breeding, the term biotechnology (often abbreviated as biotech) usually means the gene engineering technology that revolutionized the biological sciences starting with Cohen and Boyers demonstration of DNA cloning in their Stanford lab in 1973.

Since the first DNA cloning experiments over 40 years ago, genetic engineering techniques have developed to create engineered biological molecules, genetically designed microorganisms and cells, ways to find new genes and figure out how they work, and even transgenic animals and plants. In the midst of this bioengineering revolution, commercial applications exploded, and an industry developed around techniques like gene cloning, directed mutagenesis, DNA sequencing, RNA interference, biomolecule labeling and detection, and nucleic acid amplification.

The biotech industry broadly segments into the medical and agricultural markets. Although enterprising biotechnology is also being applied to other exciting areas like the industrial production of chemicals and bioremediation, the use in these areas is still specialized and limited. On the other hand, the medical and agricultural industries have each undergone a biotech revolution with newand often controversial research efforts, development programs, and business strategies to discover, alter, or produce novel biomolecules and organisms using bioengineering.

Biotechnology introduced a whole new approach to drug development that did not easily integrate into the chemically-focused approach most of the established pharmaceutical companies were using. This shift precipitated a rash of start-up companies starting with the founding of Cetus (now part of Novartis Diagnostics) and Genentech in the mid-1970s.

Since there was an established venture capital community for the high-tech industry in Silicon Valley, many of the early biotechnology companies also clustered in the San Francisco Bay Area. Over the years, several hundreds of start-up companies have been founded and hot-spots have also developed in the US around Seattle, San Diego, North Carolina's Research Triangle Park, Boston, and Philadelphia, as well as a number of international locations including areas around Berlin, Heidelberg, and Munich in Germany, Oxford and Cambridge in the UK, and the Medicon Valley in eastern Denmark and southern Sweden.

Medical biotech, with revenues exceeding $150 billion annually, receives the bulk of biotech investment and research dollars. Even the term biotech is often used synonymously with this segment. This part of biotech constellates around the drug discovery "pipeline" that starts with basic research to identify genes or proteins associated with particular diseases which could be used as drug targets and diagnostic markers. Once a new gene or protein target is found, thousands of chemicals are screened to find potential drugs that affect the target.

The chemicals that look like they might work as drugs (sometimes known as "hits") then need to be optimized, checked for toxic side effects, and, finally, tested in clinical trials.

Biotech has been instrumental in the initial drug discovery and screening stages. Most major pharmaceutical companies have active target-discovery research programs heavily reliant on biotechnology, and smaller new companies such as Exelixis, BioMarin Pharmaceuticals, and Cephalon do focused drug discovery and development often using unique proprietary techniques. In addition to direct drug development, there are companies like Abbott Diagnostics and Becton-Dickenson that are looking for ways to use new disease-related genes to create new clinical diagnostics.

A lot of these tests identify the most responsive patients for new drugs coming into the market. Also, supporting research for new drugs is a long list of research and lab supply companies that provide basic kits, reagents, and equipment. For example, companies such as Life Technologies, Thermo-Fisher, Promega and a host of others provide lab tools and equipment for bioscience research, and companies such as Molecular Devices and DiscoveRx provide specially engineered cells and detection systems for screening potential new drugs.

The same biotechnology used for drug development can also improve agricultural and food products. However, unlike with pharmaceuticals, genetic engineering did not generate a rash of new ag-biotech start-ups. The difference may be that, despite the technological leap forward, biotech did not fundamentally change the nature of the agricultural industry. Manipulating crops and livestock to optimize genetics to enhance utility and improve yields has been going on for thousands of years. In a way, bioengineering just provides a convenient new method.

Established agricultural companies, such as Dow and Monsanto, simply integrated biotech into their R&D programs.

Most of the focus on ag-biotech is on crop improvement, which, as a business, has been quite successful. Since the first genetically modified corn was introduced in 1994, transgenic crop staples such as wheat, soybean, and tomatoes have become the norm. Now, more than 90% of US-grown corn, soybeans, and cotton are bioengineered. Although lagging behind bioengineered plants, use of biotechnology for farm animal improvement is also pretty prevalent.

Remember Dolly, the first cloned sheep? That was in 1996. Now animal cloning is common, and it's clear transgenic farm animals are on the immediate horizon based on headlines highlighting recent developments on the Federation of Animal Societies' website. Although genetically modified organisms (GMOs) have generated a lot of controversy in recent years, ag-biotech has become pretty well established. According to the 2011 International Service for the Acquisition of Agri-biotech Applications' (ISAAA) 2011 report, 160 million hectares of GMO crops were planted in 2011 with sales of over $160 billion in engineered grain.

Read the original here:
Biotechnology and the Biotech Industry

Posted in Biotechnology | Comments Off on Biotechnology and the Biotech Industry

Biotechnology Definition | Investopedia

Posted: July 12, 2018 at 12:49 am

What is 'Biotechnology'

Biotechnology is the use of living organisms to make products or run processes. Biotechnology is best known for its huge role in the field of medicine, and is also used in other areas such as food and fuel.

Biotechnology involves understanding how living organisms function at the molecular level, so it combines a number of disciplines including biology, physics, chemistry, mathematics, science and technology. Modern biotechnology continues to make very significant contributions to extending the human lifespan and improving the quality of life through numerous ways, including providing products and therapies to combat diseases, generating higher crop yields, and using biofuels to reduce greenhouse gas emissions. Hungarian engineer Karl Ereky reportedly coined the term biotechnology, which is often referred to as biotech, in 1919.

Biotechnology in its basic form has existed for thousands of years, dating back to an era when humans first learned to produce bread, beer and wine using the natural process of fermentation. For centuries, the principles of biotechnology were restricted to agriculture, such as harvesting better crops and improving yields by using the best seeds, and breeding livestock.

The field of biotechnology began to develop rapidly from the 19thcentury, with the discovery of microorganisms, Gregor Mendels study of genetics, and ground-breaking work on fermentation and microbial processes by giants in the field such as Pasteur and Lister. Early 20thcentury biotechnology led to the major discovery by Alexander Fleming of penicillin, which went into large-scale production in the 1940s.

Biotechnology took off from the 1950s, spurred by a better understanding in the post-war period of cell function and molecular biology. Every decade since then produced major breakthroughs in biotechnology. These include the discovery of the 3D structure of DNA in the '50s; insulin synthesis and the development of vaccines for measles, mumps and rubella in the '60s; massive strides in DNA research in the '70s; the development of the first biotech-derived drugs and vaccines to treat diseases such as cancer and hepatitis B in the '80s; the identification of numerous genes and the introduction of new treatments in decades for managing multiple sclerosis and cystic fibrosis in the '90s; and the completion of the human genome sequence in the '90s, which made it possible for scientists worldwide to research new treatments for diseases with genetic origins like cancer, heart disease, and Alzheimers.

The biotechnology sector has grown by leaps and bounds since the 1990s. The industry has spawned giant companies in the medical space such as Gilead Sciences, Amgen, Biogen Idec and Celgene. At the other extreme are thousands of small, dynamic biotech companies, many of which are engaged in various aspects of the medical industry such as drug development, genomics, or proteomics, while others areinvolved in areas like bioremediation, biofuels and food products.

See more here:
Biotechnology Definition | Investopedia

Posted in Biotechnology | Comments Off on Biotechnology Definition | Investopedia

Page 1,370«..1020..1,3691,3701,3711,372..1,3801,390..»